Financier | Commitments |
---|---|
Health Emergency Preparedness and Response Multi-Donor Trust | 3.00 |
IDA Credit | 23.31 |
P173851
Closed
Djibrilla Karamoko
Republic of Congo
April 9, 2020
(as of board presentation)
April 20, 2020
May 26, 2020
US$ 26.31 million
Ministry of Health and Population
2020
US$ 26.31 million
N/A
Substantial
June 30, 2024
No
BANK APPROVED
June 28, 2024
Financier | Commitments |
---|---|
Health Emergency Preparedness and Response Multi-Donor Trust | 3.00 |
IDA Credit | 23.31 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | N/A |
IDA Commitment | 23.31 |
IBRD + IDA Commitment | 23.31 |
Lending Instrument | |
---|---|
Grant Amount | 3.00 |
Total Project Cost** | 26.31 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
May 26, 2023 | IDA-66340 | Int Charges | 39,873.18 |
Apr 5, 2024 | IDA-71940 | Loan Disb | 1,000,869.10 |
Apr 22, 2024 | IDA-69530 | Loan Disb | 1,018,826.56 |
May 13, 2024 | IDA-66340 | Loan Disb | -1,820,739.20 |
Nov 20, 2023 | IDA-66340 | Int Charges | 40,937.13 |
Nov 20, 2023 | IDA-66340 | Int Charges | 40,937.13 |
Nov 20, 2023 | IDA-66340 | Int Charges | 24,562.27 |
Nov 20, 2023 | IDA-69530 | Int Charges | 15,997.50 |
Nov 20, 2023 | IDA-69530 | Int Charges | 15,997.50 |
Nov 20, 2023 | IDA-69530 | Int Charges | 3,199.50 |
Apr 20, 2020 | IDA-66340 | Loan Commitment | 11,310,000.00 |
Jun 29, 2022 | IDA-71940 | Loan Commitment | 29,670,000.00 |
Jun 2, 2021 | IDA-69530 | Loan Commitment | 12,000,000.00 |
Jun 30, 2024 | IDA-66340 | Loan Cancel | 1,990,801.60 |
Jun 30, 2024 | IDA-69530 | Loan Cancel | 3,869,995.50 |
Jun 30, 2024 | IDA-71940 | Loan Cancel | 5,924,590.50 |
Jun 25, 2024 | IDA-69530 | Loan Disb | 351,349.97 |
May 20, 2024 | IDA-69530 | Int Charges | 3,336.65 |
May 20, 2024 | IDA-69530 | Int Charges | 19,673.13 |
May 20, 2024 | IDA-69530 | Int Charges | 19,673.13 |
May 20, 2024 | IDA-66340 | Int Charges | 41,254.43 |
May 20, 2024 | IDA-66340 | Int Charges | 41,254.43 |
May 20, 2024 | IDA-66340 | Int Charges | 24,752.64 |
May 7, 2024 | IDA-71940 | Loan Disb | 998,059.70 |
May 7, 2024 | IDA-71940 | Loan Disb | 1,016,068.94 |
Feb 9, 2024 | IDA-69530 | Loan Disb | 1,611,844.00 |
Feb 9, 2024 | IDA-66340 | Loan Disb | 253,754.42 |
Aug 31, 2020 | IDA-66340 | Loan Disb | 2,286,601.50 |
Aug 6, 2020 | IDA-66340 | Loan Disb | 79,587.76 |
Nov 19, 2020 | IDA-66340 | Int Charges | 10,748.25 |
Nov 19, 2020 | IDA-66340 | Int Charges | 10,748.25 |
May 31, 2021 | IDA-66340 | Int Charges | 1,659.31 |
May 31, 2021 | IDA-66340 | Int Charges | 35,276.77 |
May 31, 2021 | IDA-66340 | Int Charges | 35,276.77 |
May 31, 2021 | IDA-66340 | Int Charges | 21,166.07 |
Dec 23, 2020 | IDA-66340 | Loan Disb | 65,429.09 |
Nov 19, 2020 | IDA-66340 | Int Charges | 4,837.60 |
Nov 19, 2020 | IDA-66340 | Loan Disb | 3,094,364.80 |
Sep 18, 2020 | IDA-66340 | Loan Disb | 574,103.30 |
Jul 16, 2020 | IDA-66340 | Loan Disb | 2,341,233.80 |
Oct 14, 2020 | IDA-66340 | Loan Disb | 497,887.62 |
Dec 8, 2020 | IDA-66340 | Loan Disb | 55,079.96 |
Dec 8, 2020 | IDA-66340 | Loan Disb | 55,079.95 |
Nov 17, 2020 | IDA-66340 | Loan Disb | 108,071.64 |
May 19, 2022 | IDA-69530 | Int Charges | 7,818.09 |
May 19, 2022 | IDA-69530 | Int Charges | 7,818.09 |
May 19, 2022 | IDA-69530 | Int Charges | 1,556.25 |
May 19, 2022 | IDA-66340 | Int Charges | 18,473.88 |
May 19, 2022 | IDA-66340 | Int Charges | 30,789.79 |
May 19, 2022 | IDA-66340 | Int Charges | 30,789.79 |
Nov 26, 2021 | IDA-66340 | Int Charges | 32,983.21 |
Nov 26, 2021 | IDA-66340 | Int Charges | 32,983.21 |
Nov 26, 2021 | IDA-66340 | Int Charges | 19,789.94 |
Nov 15, 2022 | IDA-69530 | Int Charges | 7.29 |
Nov 15, 2022 | IDA-69530 | Int Charges | 15,249.10 |
Nov 15, 2022 | IDA-69530 | Int Charges | 15,249.10 |
Nov 15, 2022 | IDA-69530 | Int Charges | 3,042.53 |
Nov 15, 2022 | IDA-66340 | Int Charges | 18,270.33 |
Nov 15, 2022 | IDA-66340 | Int Charges | 30,450.54 |
Nov 15, 2022 | IDA-66340 | Int Charges | 30,450.54 |
Nov 23, 2022 | IDA-66340 | Loan Disb | 2,265,629.00 |
Feb 7, 2022 | IDA-69530 | Loan Disb | 2,238,434.00 |
Feb 7, 2022 | IDA-69530 | Loan Disb | 87,388.64 |
Mar 10, 2022 | IDA-69530 | Loan Disb | 715,717.10 |
Feb 11, 2022 | IDA-69530 | Loan Disb | 1,395,642.90 |
May 26, 2023 | IDA-69530 | Int Charges | 7.52 |
May 26, 2023 | IDA-69530 | Int Charges | 15,735.34 |
May 26, 2023 | IDA-69530 | Int Charges | 15,735.34 |
May 26, 2023 | IDA-69530 | Int Charges | 3,147.07 |
Jun 30, 2023 | IDA-71940 | Loan Cancel | 21,134,712.00 |
May 26, 2023 | IDA-66340 | Int Charges | 23,923.89 |
May 26, 2023 | IDA-66340 | Int Charges | 39,873.18 |
Name | Review | Date |
---|---|---|
Progress towards achievement of PDO | Moderately Satisfactory | 2024-06-03 |
Project Management | Moderately Unsatisfactory | 2024-06-03 |
Procurement | Moderately Satisfactory | 2024-06-03 |
Financial Management | Moderately Unsatisfactory | 2024-06-03 |
Monitoring and Evaluation | Moderately Unsatisfactory | 2024-06-03 |
Overall Implementation Progress (IP) | Moderately Unsatisfactory | 2024-06-03 |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents | Value | 0.00 | 19.00 | 18.00 |
Date | April 13, 2020 | November 30, 2023 | April 30, 2024 | |
Comment |
Country-specific risk communication and community engagement strategy developed and disseminated | Value | 0.00 | 3.00 | 3.00 |
Date | April 13, 2020 | November 30, 2023 | April 30, 2024 | |
Comment |
Acute healthcare facilities with isolation capacity | Value | 0.00 | 19.00 | 16.00 |
Date | April 20, 2020 | November 30, 2023 | April 30, 2024 | |
Comment |
Suspected cases of COVID-19 reported and investigated based on national guidelines | Value | 0.00 | 94.00 | 90.00 |
Date | April 13, 2020 | November 30, 2023 | April 30, 2024 | |
Comment |
Population vaccinated with a COVID-19 vaccine | Value | 0.00 | 11.59 | 30.00 |
Date | April 30, 2021 | November 30, 2023 | April 30, 2024 | |
Comment |
Number of departments with less than 10% vaccinated | Value | 12.00 | 9.00 | 0.00 |
Date | ||||
Comment |
Proportion of women among those vaccinated | Value | 0.00 | 30.00 | 0.00 |
Date | ||||
Comment |
Proportion of indigenous women vaccinated | Value | 0.00 | 0.00 | 0.00 |
Date | ||||
Comment |
Health centers with adequate WASH facilities | Value | 77.00 | 79.00 | 124.00 |
Date | April 13, 2020 | November 30, 2023 | April 30, 2024 | |
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Health staff trained in infection prevention and control per MOH-approved protocols | Value | 0.00 | 544.00 | 1000.00 |
Date | April 20, 2020 | November 30, 2023 | April 30, 2024 | |
Comment |
Communication campaigns about COVID-19 broadcasted to communities | Value | 0.00 | 9.00 | 20.00 |
Date | April 20, 2020 | November 30, 2023 | April 30, 2024 | |
Comment |
M&E systems established to monitor COVID-19 preparedness and response plan | Value | 0.00 | 2.00 | 1.00 |
Date | April 20, 2020 | November 30, 2023 | April 29, 2022 | |
Comment |
Number of departments with a referral system to care for COVID-19 patients | Value | 0.00 | 12.00 | 4.00 |
Date | April 20, 2020 | November 30, 2023 | April 30, 2024 | |
Comment |
Mobile community health promotion and COVID-19 sensitization campaigns, coupled with mobile vaccination | Value | 0.00 | 0.00 | 24.00 |
Date | May 31, 2022 | November 30, 2023 | April 30, 2024 | |
Comment |
COVID-19 Response M&E reports prepared by the Technical Committee | Value | 0.00 | 244.00 | 120.00 |
Date | April 20, 2020 | November 30, 2023 | April 30, 2024 | |
Comment |
Acute healthcare facilities with triage capacity | Value | 0.00 | 8.00 | 16.00 |
Date | April 20, 2020 | November 30, 2023 | April 30, 2024 | |
Comment |
Percentage of received grievances addressed through the GRM in a timely mannner | Value | 0.00 | 0.00 | 90.00 |
Date | September 18, 2020 | November 30, 2023 | April 30, 2024 | |
Comment |
Multi-sectoral simulation exercises conducted with results incorporated into national COVID-19 preparedness and response plans | Value | 0.00 | 1.00 | 1.00 |
Date | April 20, 2020 | November 30, 2023 | April 30, 2024 | |
Comment |
Designated laboratories with staff trained to conduct COVID-19 diagnosis | Value | 0.00 | 12.00 | 24.00 |
Date | April 20, 2020 | November 30, 2023 | April 30, 2024 | |
Comment |
Pressure Swing Absorption (PSA) oxygen generating plant installed and functional | Value | 0.00 | 4.00 | 2.00 |
Date | May 31, 2022 | April 30, 2024 | April 30, 2024 | |
Comment |
At least one report on waste-disposal activities conducted by health facilities has been published in the last quarter | Value | No | Yes | Yes |
Date | May 31, 2022 | November 30, 2023 | April 30, 2024 | |
Comment |
Absorption rate of COVID-19 vaccines acquired | Value | 0.00 | 32.10 | 80.00 |
Date | May 1, 2022 | November 30, 2023 | April 30, 2024 | |
Comment |
Country has updated preparedness plans (multi-year and annual) | Value | No | Yes | Yes |
Date | March 31, 2022 | November 30, 2023 | April 30, 2024 | |
Comment |
Country has a comprehensive health sector emergency response coordination mechanism with a functional national emergency operationscentre | Value | No | Yes | Yes |
Date | March 31, 2022 | November 30, 2023 | April 30, 2024 | |
Comment |